Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Carolyn Wolff
Observed name:
Wolff, Carolyn
Institutions:
United States Food and Drug Administration,
Federal Trade Commission
Observed institutions:
United States Food and Drug Administration,
Federal Trade Commission
ORCID:
0000-0003-0621-6526
Observed ORCID:
0000-0003-0621-6526
OpenAlex ID:
A5004675636
The impact of the abuse-deterrent reformulation of extended-release OxyContin on prescription pain reliever misuse and heroin initiation
2019
·
Carolyn Wolff
, William N. Dowd
, et al.
·
Addictive Behaviors
·
31
New Opioid Analgesic Approvals and Outpatient Utilization of Opioid Analgesics in the United States, 1997 through 2015
2018
·
Grace Chai
, Jing Xu
, et al.
·
Anesthesiology
·
16
Congestion Pricing as a Traffic Management Tool: Evaluating the Impacts at New York City’s Interstate Crossings
2007
·
Carolyn Wolff
, Pierre Vilain
·
Transportation Research Board 86th Annual MeetingTransportation Research Board
·
5
Willingness to pay to standardize patient medication information
2020
·
Bern Caudill Dealy
, Aaron Kearsley
, et al.
·
Applied Economics
·
3
Health Equity and Access to COVID-19 Treatments Available through Emergency Use Authorizations
2024
·
Candon Johnson
, Carolyn Wolff
, et al.
·
Journal of Racial and Ethnic Health Disparities
·
2
A survey on perceived medication guide reading and comprehension ease among US adults
2024
·
Paul R Jones
, Jonas Santiago
, et al.
·
Health Promotion International
·
2
Evaluating Congestion Pricing Impacts Under Peak Spreading
2007
·
Wolff, Carolyn
, Vilain, Pierre
·
RePEc: Research Papers in Economics
·
2
Measuring the Willingness-to-pay for standardizing medication information: a two-pronged stated preference approach
2023
·
Bern Caudill Dealy
, Carolyn Wolff
, et al.
·
Applied Economics
Prospective Evaluation of Health Communication Effects on Market Outcomes
2022
·
Rosemarie L. Summers
, Dallas W. Wood
, et al.
·
Journal of Benefit-Cost Analysis
Why are pharmacy acquisition costs and consumer prescription drug price indices apparently diverging?
2020
·
Carolyn Wolff
, Randall Lutter
·
Health Economics
The impact of abuse-deterrent formulation of extended-release OxyContin on non-medical use of prescription pain relievers and heroin use
2018
·
Mir M. Ali
, Lukas Glos
, et al.
·
Annual Conference of the American Society of Health Economists (ASHEcon)
Do work incentives work? three essays on the impacts for physicians and welfare recipients
2013
·
Carolyn Wolff
·
NC Digital Online Collection of Knowledge and Scholarship (The University of North Carolina at Greensboro)
Salick Cardiovascular Centers: Business Plan
2003
·
Regina E. Herzlinger
, Kaushik Sen
, et al.
Show more works
View as search
Works count:
14
Citation count:
61
H-index:
3
I10-index:
2
Year
Topic
Type